Browsing Folkehelseinstituttet by Title
Now showing items 3250-3269 of 8887
-
Helseøkonomisk analyse av bevacizumab+paclitaxel sammenlignet med paclitaxel alene som førstelinjebehandling ved metastatisk brystkreft
(Rapport, Peer reviewed; Research report, 2009-04)BACKGROUND The Norwegian Knowledge Centre for the Health Services has been commissioned by Norwegian Directorate of Health’s Cancer Programme to make an assessment of the cost per progression-free year gained associated ... -
Helseøkonomisk analyse av blødersykdommen i Norge.
(Journal article; Peer reviewed, 1980-05-20) -
Helseøkonomisk evaluering av bevacizumab ved metastatisk kolorektalcancer
(Rapport fra Kunnskapssenteret;, Research report, 2007)Vi har gjennomført en modellbasert analyse av kostnadseffektiviteten av bevacizumab som førstelinjebehandling av metastatisk kolorektalcancer (tykk- og endetarmskreft) i Norge. Vi har undersøkt effekten av å legge bevacizumab ... -
Hemorrhagiske diateser. Oversikt og inndeling
(Journal article; Peer reviewed, 1956) -
Hemostasis Manual
(Book; Book, 1967) -
Hemostasis Manual 1968
(Book, 1968) -
The hemostatic effect of Adona (AC-17).
(Journal article; Peer reviewed, 1962-07-15) -
Hepatitis B virus elimination status and strategies in circumpolar countries, 2020
(Peer reviewed; Journal article, 2021) -
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
(Peer reviewed; Journal article, 2016)Background and Aims There is limited data on hepatitis C (HCV) treatment uptake among people who inject drugs including individuals receiving opioid substitution treatment (OST). We aimed to calculate cumulative HCV treatment ... -
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
(Peer reviewed; Journal article, 2016)Background and Aims There is limited data on hepatitis C (HCV) treatment uptake among people who inject drugs including individuals receiving opioid substitution treatment (OST). We aimed to calculate cumulative HCV treatment ... -
Hepatitis E in Norway: seroprevalence in humans and swine
(Peer reviewed; Journal article, 2017) -
Hepatitis E in Pregnant Women and the Potential Use of HEV Vaccine to Prevent Maternal Infection and Mortality
(Peer reviewed; Journal article, 2019) -
Hepatitis E Virus (HEV) Synopsis: General Aspects and Focus on Bangladesh
(Peer reviewed; Journal article, 2022)HEV is the most common cause of acute hepatitis globally. This review summarizes the latest knowledge on the epidemiology, clinical characteristics, testing, and treatment of HEV infection. We also focused on Bangladesh ... -
Hepatitis E Virus (HEV) Synopsis: General Aspects and Focus on Bangladesh
(Peer reviewed; Journal article, 2023)HEV is the most common cause of acute hepatitis globally. This review summarizes the latest knowledge on the epidemiology, clinical characteristics, testing, and treatment of HEV infection. We also focused on Bangladesh ... -
Hepatitis of unknown aetiology in children - epidemiological overview of cases reported in Europe, 1 January to 16 June 2022
(Peer reviewed; Journal article, 2022) -
Hepatitt B-virus. Strategimøte 2007
(Research report, 2007)Hepatitt B-virus: Strategimøte i 2007 i regi av de medisinsk mikrobiologiske laboratoriene i Norge med oppsummering av status på fagområdet, anbefalinger om diagnostikk og abstrakter av foredragene. -
Hepatitt C virus. Strategimøte 2006. Forelesningsmanuskripter og kort referat med anbefalinger
(Strategirapport fra Referansegruppe for ekstern kvalitetssikring i virologi og serologi / Folkehelseinstituttet, Research report, 1996) -
Herbal medicine use in pregnancy: results of a multinational study
(Journal article, 2013) -
Hereditary thrombocytopenia with excessively prolonged bleeding time.
(Journal article; Peer reviewed, 1969)